Literature DB >> 30514902

Palmitoylation stabilizes PD-L1 to promote breast tumor growth.

Yi Yang1, Jung-Mao Hsu1, Linlin Sun1,2, Li-Chuan Chan1,3, Chia-Wei Li1, Jennifer L Hsu1,3, Yongkun Wei1, Weiya Xia1, Junwei Hou1, Yufan Qiu1,4, Mien-Chie Hung5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30514902      PMCID： PMC6318320          DOI： 10.1038/s41422-018-0124-5

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  15 in total

1.  Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.

Authors:  Cameron L Noland; Sarah Gierke; Paul D Schnier; Jeremy Murray; Wendy N Sandoval; Meredith Sagolla; Anwesha Dey; Rami N Hannoush; Wayne J Fairbrother; Christian N Cunningham
Journal:  Structure       Date:  2015-12-24       Impact factor: 5.006

Review 2.  Palmitoylation of proteins in cancer.

Authors:  Marilyn D Resh
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

Review 3.  Palmitoylation: policing protein stability and traffic.

Authors:  Maurine E Linder; Robert J Deschenes
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

Review 4.  Regulation and Function of the PD-L1 Checkpoint.

Authors:  Chong Sun; Riccardo Mezzadra; Ton N Schumacher
Journal:  Immunity       Date:  2018-03-20       Impact factor: 31.745

5.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

Review 6.  PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.

Authors:  Weiping Zou; Jedd D Wolchok; Lieping Chen
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

Review 7.  Emerging Roles of DHHC-mediated Protein S-palmitoylation in Physiological and Pathophysiological Context.

Authors:  Indranil De; Sushabhan Sadhukhan
Journal:  Eur J Cell Biol       Date:  2018-03-22       Impact factor: 4.492

8.  Palmitoylation regulates the intracellular trafficking and stability of c-Met.

Authors:  David T Coleman; Alana L Gray; Steven J Kridel; James A Cardelli
Journal:  Oncotarget       Date:  2016-05-31

9.  Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.

Authors:  Chia-Wei Li; Seung-Oe Lim; Weiya Xia; Heng-Huan Lee; Li-Chuan Chan; Chu-Wei Kuo; Kay-Hooi Khoo; Shih-Shin Chang; Jong-Ho Cha; Taewan Kim; Jennifer L Hsu; Yun Wu; Jung-Mao Hsu; Hirohito Yamaguchi; Qingqing Ding; Yan Wang; Jun Yao; Cheng-Chung Lee; Hsing-Ju Wu; Aysegul A Sahin; James P Allison; Dihua Yu; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Nat Commun       Date:  2016-08-30       Impact factor: 14.919

Review 10.  Palmitoylation: a protein S-acylation with implications for breast cancer.

Authors:  Alison M Anderson; Mark A Ragan
Journal:  NPJ Breast Cancer       Date:  2016-10-19
View more
  52 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Protein S-Palmitoylation and Lung Diseases.

Authors:  Zeang Wu; Rubin Tan; Liping Zhu; Ping Yao; Qinghua Hu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Mechanisms Controlling PD-L1 Expression in Cancer.

Authors:  Jong-Ho Cha; Li-Chuan Chan; Chia-Wei Li; Jennifer L Hsu; Mien-Chie Hung
Journal:  Mol Cell       Date:  2019-10-24       Impact factor: 17.970

4.  Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma.

Authors:  Xiaoyang Wang; Jianbo Tian; Qianyu Zhao; Nan Yang; Pingting Ying; Xiating Peng; Danyi Zou; Ying Zhu; Rong Zhong; Ying Gao; Jiang Chang; Xiaoping Miao
Journal:  Arch Toxicol       Date:  2020-05-09       Impact factor: 5.153

5.  The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.

Authors:  Cheng-Wei Chou; Ri-Yao Yang; Li-Chuan Chan; Ching-Fei Li; Linlin Sun; Heng-Huan Lee; Pei-Chih Lee; Yuh-Pyng Sher; Haoqiang Ying; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

6.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.

Authors:  Binghai Zhou; Lei Guo; Bo Zhang; Shuang Liu; Kewei Zhang; Jiuliang Yan; Wentao Zhang; Mincheng Yu; Zheng Chen; Yongfeng Xu; Yongsheng Xiao; Jian Zhou; Jia Fan; Hui Li; Qinghai Ye
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

8.  IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Authors:  Li-Chuan Chan; Chia-Wei Li; Weiya Xia; Jung-Mao Hsu; Heng-Huan Lee; Jong-Ho Cha; Hung-Ling Wang; Wen-Hao Yang; Er-Yen Yen; Wei-Chao Chang; Zhengyu Zha; Seung-Oe Lim; Yun-Ju Lai; Chunxiao Liu; Jielin Liu; Qiongzhu Dong; Yi Yang; Linlin Sun; Yongkun Wei; Lei Nie; Jennifer L Hsu; Hui Li; Qinghai Ye; Manal M Hassan; Hesham M Amin; Ahmed O Kaseb; Xin Lin; Shao-Chun Wang; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

9.  Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma.

Authors:  Xian Sun; Chia-Wei Li; Wei-Jan Wang; Mei-Kuang Chen; Hui Li; Yun-Ju Lai; Jennifer L Hsu; Paul B Koller; Li-Chuan Chan; Pei-Chih Lee; Fang-Ju Cheng; Clinton Yam; Gong-Yan Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

Review 10.  Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway.

Authors:  Qian Wu; Li Jiang; Si-Cheng Li; Qiao-Jun He; Bo Yang; Ji Cao
Journal:  Acta Pharmacol Sin       Date:  2020-03-09       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.